Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI

被引：2
作者：
Vavuranakis, Manolis [1 ,2 ]
Boudoulas, Konstantinos D. [2 ]
Katsarou, Ourania [1 ]
Vrachatis, Dimitrios A. [1 ]
Kalogeras, Konstantinos I. [1 ]
Papaioannou, Theodore G. [1 ]
Siasos, Gerasimos [1 ]
Oikonomou, Evangelos [1 ]
Lazaros, George [1 ]
Vavuranakis, Michael-Andreas [1 ]
Deftereos, Spyridon [3 ,4 ]
Tousoulis, Dimitrios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Dept Cardiol 1, Athens, Greece
[2] Ohio State Univ, Dept Cardiovasc Med, Columbus, OH 43210 USA
[3] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Cardiol 2, Athens, Greece
[4] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
来源：
CURRENT PHARMACEUTICAL DESIGN | 2017年 / 23卷 / 09期
关键词：
ASD; LAA; PFO; transcatheter; warfarin; coumadin; antiplatelet; NOAC; LEFT ATRIAL APPENDAGE; PATENT FORAMEN OVALE; TRANSCATHETER OCCLUSION PLAATO; TRANSIENT ISCHEMIC ATTACK; 2010 ESC GUIDELINES; HIGH-RISK PATIENTS; PERCUTANEOUS CLOSURE; STROKE PREVENTION; PARADOXICAL EMBOLISM; ORAL ANTICOAGULANTS;
D O I：
10.2174/1381612822666161221143416
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Transcatheter interventions for structural heart disease represent an emerging field in interventional cardiology. Undoubtedly, there is an absolute necessity for antiplatelet and/or anticoagulation treatment prior, during and post such interventions. However, currently administered regimens are mainly based in expert consensus recommendations. In the present review we aim to summarize data regarding anti platelet and/or anticoagulation treatment in the following transcatheter structural heart interventions: left atrial appendage closure, atrial septal defect closure, patent foramen oval closure, paravalvular leak closure.
引用
收藏
页码：1328 / 1333
页数：6
相关论文
共 90 条
  • [1] [Anonymous], CIRC CARDIOVASC INTE
  • [2] [Anonymous], RESPECT 10 YEAR DAT
  • [3] [Anonymous], 1877, Thrombose und Embolie: Vorlesung uber allgemeine Pathologie
  • [4] [Anonymous], 2014, CIRCULATION, DOI DOI 10.1161/01.cir.0000441139.02102.80
  • [5] [Anonymous], ESC GUID MAN GROWN U
  • [6] [Anonymous], MAYO CLIN P
  • [7] [Anonymous], 2013, N ENGL J MED, DOI DOI 10.1056/NEJMOA1301440
  • [8] Bayard YL, 2010, EUROINTERVENTION, V6, P220, DOI 10.4244/
  • [9] Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke
    Bedard, Elisabeth
    Rodes-Cabau, Josep
    Houde, Christine
    Mackey, Ariane
    Rivest, Donald
    Cloutier, Stephanie
    Noel, Martin
    Marrero, Alier
    Cote, Jean-Marc
    Chetaille, Philippe
    Delisle, George
    Leblanc, Marie-Helene
    Bertrand, Olivier F.
    [J]. STROKE, 2007, 38 (01) : 100 - 104
  • [10] Beurtheret S, 2010, J HEART VALVE DIS, V19, P326
123456789